CID 108161

Iododoxorubicin

Structural Information

Molecular Formula
C27H28INO10
SMILES
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)I
InChI
InChI=1S/C27H28INO10/c1-10-22(28)13(29)6-17(38-10)39-15-8-27(36,16(31)9-30)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15,17,22,30,33,35-36H,6-9,29H2,1-2H3/t10-,13-,15-,17-,22+,27-/m0/s1
InChIKey
PDQGEKGUTOTUNV-TZSSRYMLSA-N
Compound name
(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-iodo-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
Related CIDs

2D Structure

compound 2d structure
4
Annotation Hits

73
References

11056
Patents

653.0758 Da
Monoisotopic Mass

2.9
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 654.08308 234.3
[M+Na]+ 676.06502 232.1
[M-H]- 652.06852 230.4
[M+NH4]+ 671.10962 235.0
[M+K]+ 692.03896 237.5
[M+H-H2O]+ 636.07306 221.8
[M+HCOO]- 698.07400 232.9
[M+CH3COO]- 712.08965 258.8
[M+Na-2H]- 674.05047 220.7
[M]+ 653.07525 231.6
[M]- 653.07635 231.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe